Author + information
- Received June 11, 2018
- Revision received January 8, 2019
- Accepted January 10, 2019
- Published online March 4, 2019.
- Omar K. Khalique, MDa,∗ (, )@OKhaliqueMD,
- João L. Cavalcante, MDb,
- Dipan Shah, MDc,
- Andrada C. Guta, MDd,e,
- Yang Zhan, MDc,
- Nicolo Piazza, MD, PhDf and
- Denisa Muraru, MD, PhDe,g
- aDepartment of Medicine, Division of Cardiology, Structural Heart and Valve Center, Columbia University Medical Center, New York, New York
- bMinneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota
- cDivision of Cardiology, Houston Methodist Hospital, Houston, Texas
- dCarol Davila University of Medicine and Pharmacy, Department of Cardiology, Bucharest, Romania
- eDepartment of Cardiac, Thoracic, and Vascular Sciences, University of Padua, Padua, Italy
- fMcGill University Heart Centre, Division of Cardiology, Montreal, Quebec, Canada
- gIRCCS, Instituto Auxologico Italiano, S. Luca Hospital, University of Milano-Bicocca, Milan, Italy
- ↵∗Address for correspondence:
Dr. Omar Khalique, Columbia University Medical Center, Department of Medicine, 5-501C, 177 Fort Washington Avenue, New York, New York 10032.
The characterization of tricuspid valve and right-heart anatomy has been gaining significant interest in the setting of new percutaneous transcatheter interventions for tricuspid regurgitation. Multimodality cardiac imaging provides a wealth of information about the anatomy and function of the tricuspid valve apparatus, right ventricle, and right atrium, which is pivotal for diagnosis and prognosis and for planning of percutaneous interventions. The present review describes the role of echocardiography, cardiac magnetic resonance, and multidetector row cardiac computed tomography for right heart and tricuspid valve assessment.
Dr. Khalique is a member of the Speakers Bureau for Edwards Lifesciences; and is a consultant for Cephea Valves and Jenavalve. Dr. Cavalcante has received research support from Medtronic; and is a consultant for Medtronic and Mitralign. Dr. Muraru is a consultant for, has received research support from, and is a member of the Speakers Bureau for GE Healthcare and TomTec Imaging. Dr. Piazza is a consultant for HighLife, Medtronic, MicroPort, and Cephea. Dr. Guta has received a research grant from the Romanian Society of Cardiology. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received June 11, 2018.
- Revision received January 8, 2019.
- Accepted January 10, 2019.
- 2019 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.